{"id":"W2567822129","doi":"10.1016/j.jtho.2016.11.2090","title":"PUB119 Lanreotide in Patients with Lung Neuroendocrine Tumors: The Randomized Double-Blind Placebo-Controlled International Phase 3 SPINET Study","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lanreotide; Medicine; Neuroendocrine tumors; Clinical endpoint; Internal medicine; Oncology; Placebo; Phases of clinical research; Lung cancer; Lung; Chemotherapy; Randomized controlled trial; Gastroenterology; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001315826,0.001769976,0.003473098,0.0004150947,0.0004583013,0.001196137,0.0009287432,0.002244411,0.007146862],"category_scores_gemma":[0.001244318,0.0007132289,0.00217498,0.000453284,0.001384029,0.001312176,0.0004279699,0.003424298,0.00133569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006760515,"about_ca_system_score_gemma":0.001253561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00114453,"about_ca_topic_score_gemma":0.002223168,"domain_scores_codex":[0.9995054,0.0002467986,0.00002716767,0.00008578386,0.00004110498,0.00009371688],"domain_scores_gemma":[0.9994044,0.0001610021,0.0001342644,0.00005529904,0.00004185499,0.0002032316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9788288,0.003902988,0.0003350046,0.0005880846,0.0009148636,0.00003412909,0.00002934501,0.0002454746,0.002658357,0.00009539918,0.0009561965,0.01141147],"study_design_scores_gemma":[0.9599465,0.03782852,0.0008940642,0.00002178625,0.000396592,0.00002229309,0.000017437,0.0001559685,0.0002098732,0.00007318085,0.0004211729,0.00001247528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.978169,0.01013671,0.001123155,0.001212989,0.0009255452,0.002768517,0.002125781,0.0003584519,0.003180004],"genre_scores_gemma":[0.9798298,0.00530431,0.001563855,0.002352288,0.0006232221,0.003330907,0.002527421,0.00007720319,0.004390892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007146862,"threshold_uncertainty_score":0.02390867,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03275642882209268,"score_gpt":0.4543495624240792,"score_spread":0.4215931336019865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}